Munich - Delayed Quote • EUR
Aurinia Pharmaceuticals Inc (IKAP.MU)
As of 8:11 AM GMT+2. Market Open.
Loading Chart for IKAP.MU
DELL
- Previous Close
4.7150 - Open
4.7150 - Bid 4.6310 x --
- Ask 4.7240 x --
- Day's Range
4.7150 - 4.7150 - 52 Week Range
4.5380 - 11.1200 - Volume
200 - Avg. Volume
3 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: IKAP.MU
Performance Overview: IKAP.MU
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
IKAP.MU
42.85%
S&P 500
6.33%
1-Year Return
IKAP.MU
51.74%
S&P 500
22.59%
3-Year Return
IKAP.MU
54.29%
S&P 500
21.33%
5-Year Return
IKAP.MU
17.69%
S&P 500
73.26%
Compare To: IKAP.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IKAP.MU
Valuation Measures
As of 4/25/2024
Market Cap
679.66M
Enterprise Value
443.38M
Trailing P/E
--
Forward P/E
126.58
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.12
Price/Book (mrq)
1.93
Enterprise Value/Revenue
2.53
Enterprise Value/EBITDA
-7.03
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: IKAP.MU
IKAP.MU does not have Company Insights